Biblio
Export 1397 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is P [Clear All Filters]
“The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1541-1554, 2020.
, “Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1215-1242, 2020.
, “An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1639-1653, 2020.
, “The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 573-585, 2020.
, “Inflammation in Traumatic Brain Injury.”, J Alzheimers Dis, vol. 74, no. 1, pp. 1-28, 2020.
, “Inflammation in Traumatic Brain Injury.”, J Alzheimers Dis, vol. 74, no. 1, pp. 1-28, 2020.
, “Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 277-286, 2020.
, “Mitochondrial DNA Manipulations Affect Tau Oligomerization.”, J Alzheimers Dis, vol. 77, no. 1, pp. 149-163, 2020.
, “A Narrative Review of Alzheimer's Disease Stigma.”, J Alzheimers Dis, vol. 78, no. 2, pp. 515-528, 2020.
, “Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1279-1294, 2020.
, “New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
, “Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases.”, J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
, “Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases.”, J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
, “Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 75, no. 3, pp. 845-854, 2020.
, “Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.”, J Alzheimers Dis, vol. 79, no. 1, pp. 335-353, 2020.
, “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
, “Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.”, J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
, “Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1385-1405, 2020.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
, “Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.”, J Alzheimers Dis, vol. 74, no. 2, pp. 501-508, 2020.
, “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
,